- Home
- Healthcare professionals
- ACE Technology Guidances
- Medical Technology Guidances
- Percutaneous vertebral augmentation systems for treating patients with vertebral compression fractures
Musculoskeletal
Percutaneous vertebral augmentation systems for treating patients with vertebral compression fractures
6 June 2022
Published on 06 Jun 2022
Last Updated on 06 Jun 2022
Guidance Recommendation
The Ministry of Health’s MTAC has not recommended subsidy for percutaneous vertebral augmentation systems (PVAS) for the treatment of patients with vertebral compression fractures (VCFs).
Subsidy status
PVAS are not recommended for subsidy in patients with the abovementioned indications.